These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 14651959)
21. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease. Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254 [TBL] [Abstract][Full Text] [Related]
22. Cdk5 as a drug target for the treatment of Alzheimer's disease. Lau LF; Seymour PA; Sanner MA; Schachter JB J Mol Neurosci; 2002 Dec; 19(3):267-73. PubMed ID: 12540052 [TBL] [Abstract][Full Text] [Related]
23. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. Liu F; Su Y; Li B; Zhou Y; Ryder J; Gonzalez-DeWhitt P; May PC; Ni B FEBS Lett; 2003 Jul; 547(1-3):193-6. PubMed ID: 12860412 [TBL] [Abstract][Full Text] [Related]
24. Interaction of Tau with Fe65 links tau to APP. Barbato C; Canu N; Zambrano N; Serafino A; Minopoli G; Ciotti MT; Amadoro G; Russo T; Calissano P Neurobiol Dis; 2005 Mar; 18(2):399-408. PubMed ID: 15686969 [TBL] [Abstract][Full Text] [Related]
25. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium. Jordà EG; Verdaguer E; Canudas AM; Jiménez A; Garcia de Arriba S; Allgaier C; Pallàs M; Camins A Neuroscience; 2005; 134(3):1001-11. PubMed ID: 15979805 [TBL] [Abstract][Full Text] [Related]
26. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation. Cole AR; Soutar MP; Rembutsu M; van Aalten L; Hastie CJ; McLauchlan H; Peggie M; Balastik M; Lu KP; Sutherland C J Biol Chem; 2008 Jun; 283(26):18227-37. PubMed ID: 18460467 [TBL] [Abstract][Full Text] [Related]
27. Cdk5, a therapeutic target for Alzheimer's disease? Tsai LH; Lee MS; Cruz J Biochim Biophys Acta; 2004 Mar; 1697(1-2):137-42. PubMed ID: 15023356 [TBL] [Abstract][Full Text] [Related]
28. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
29. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
30. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. Morfini G; Szebenyi G; Brown H; Pant HC; Pigino G; DeBoer S; Beffert U; Brady ST EMBO J; 2004 Jun; 23(11):2235-45. PubMed ID: 15152189 [TBL] [Abstract][Full Text] [Related]
32. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819 [TBL] [Abstract][Full Text] [Related]
33. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease. Crews L; Patrick C; Adame A; Rockenstein E; Masliah E Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891 [TBL] [Abstract][Full Text] [Related]
34. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells. Ubeda M; Kemp DM; Habener JF Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144 [TBL] [Abstract][Full Text] [Related]
35. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts. Hernandez P; Lee G; Sjoberg M; Maccioni RB J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430 [TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. Sotiropoulos I; Catania C; Riedemann T; Fry JP; Breen KC; Michaelidis TM; Almeida OF J Neurochem; 2008 Oct; 107(2):385-97. PubMed ID: 18691381 [TBL] [Abstract][Full Text] [Related]
37. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Parr C; Carzaniga R; Gentleman SM; Van Leuven F; Walter J; Sastre M Mol Cell Biol; 2012 Nov; 32(21):4410-8. PubMed ID: 22927642 [TBL] [Abstract][Full Text] [Related]
38. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Patrick C; Crews L; Desplats P; Dumaop W; Rockenstein E; Achim CL; Everall IP; Masliah E Am J Pathol; 2011 Apr; 178(4):1646-61. PubMed ID: 21435449 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles. Qin X; Wang Y; Paudel HK Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077 [TBL] [Abstract][Full Text] [Related]
40. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]